EMA to Hold its Second Public Meeting on COVID-19 Vaccines
The agency is organizing a second public meeting on January 8, 2021 to discuss the assessment, approval, and roll-out of new COVID-19 vaccines.
The European Medicines Agency (EMA) is organizing a second public meeting regarding the assessment, approval, and roll-out of new COVID-19 vaccines. At the meeting, EMA will discuss plans to ensure the safety of COVID-19 vaccines and the roles that the European Commission and the national public health authorities will play in the roll-out of the vaccines, according to a press release dated Dec. 22, 2020.
The meeting will be held online on January 8 and will be attended by EMA executive director Emer Cooke and members of EMA’s human medicines and safety committees, among others. An online form is being made available for those who wish to submit questions to panelists at the meeting. The agency has requested that these questions be submitted by Dec. 31, 2020.
Source: EMA
Texas' MD Anderson Cancer Center Creates New Cell Therapy Institute
November 11th 2024With the launch of the Institute for Cell Therapy Discovery and Innovation, the MD Anderson Cancer Center will bring together expertise in developing cell therapies for cancer, autoimmune diseases, and infections.
